Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Inside Epstein’s infamous ‘birthday book’: Clinton’s note, poolside...
Whole milk makes a comeback in new MAHA...
Hawley pushes legal action against Meta after whistleblowers...
As Trump’s bawdy birthday message to Jeffrey Epstein...
Elon Musk agrees with JD Vance on the...
Scalise hints GOP may push nationwide crime crackdown...
Harris admits Biden ‘got tired,’ denies ‘conspiracy’ to...
GOP senator compares Israel’s Hamas fight to US...
Trump calls for death penalty for suspect in...
Jury selection still underway in Ryan Routh trial,...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Business

DOJ sues Walgreens, alleging it ‘knowingly’ filled millions of invalid prescriptions

by admin January 19, 2025
January 19, 2025
DOJ sues Walgreens, alleging it ‘knowingly’ filled millions of invalid prescriptions

The Department of Justice said Friday that it sued pharmacy giant Walgreens over allegedly dispensing millions of unlawful prescriptions.

The DOJ said that Walgreens from August 2012 until the present “knowingly” filled those prescriptions, which “lacked a legitimate medical purpose, were not valid, and/or were not issued in the usual course of professional practice.” 

“This lawsuit seeks to hold Walgreens accountable for the many years that it failed to meet its obligations when dispensing dangerous opioids and other drugs,” said Principal Deputy Assistant Attorney General Brian Boynton, head of the DOJ’s Civil Division.

Boynton said that Walgreens pharmacists filled millions of prescriptions with “clear red flags that indicated the prescriptions were highly likely to be unlawful.”

The company “systematically pressured its pharmacists to fill prescriptions, including controlled substance prescriptions, without taking the time needed to confirm their validity,” Boynton said. “These practices allowed millions of opioid pills and other controlled substances to flow illegally out of Walgreens stores.”

Some Walgreens patients died of overdose deaths shortly after getting invalid prescriptions filled at Walgreens, the DOJ alleges.

The 300-page lawsuit was filed Thursday in U.S. District Court in Chicago.

Walgreens in a statement said, “We are asking the court to clarify the responsibilities of pharmacies and pharmacists and to protect against the government’s attempt to enforce arbitrary ‘rules’ that do not appear in any law or regulation and never went through any official rulemaking process.”

“We will not stand by and allow the government to put our pharmacists in a no-win situation, trying to comply with ‘rules’ that simply do not exist,” Walgreens said.

“Walgreens stands behind our pharmacists, dedicated healthcare professionals who live in the communities they serve, filling legitimate prescriptions for FDA-approved medications written by DEA-licensed prescribers in accordance with all applicable laws and regulations.”

The suit alleges that although Walgreens issued written policies that reflected its understanding of legal obligations, the company took other actions which it knew prevented its pharmacists from complying with them.

“Walgreens prioritized profits over safety and compliance by implementing policies and practices that required pharmacists to fill prescriptions quickly and left pharmacists without enough time or resources to exercise their corresponding responsibility,” the suit said.

“One such metric was ‘Verify By Promise Time’ (VBPT), which expected a pharmacist to fill a prescription within 15 minutes for a ‘waiter’ (a customer waiting in the pharmacy store for the prescription),” the suit alleges.

“Walgreens also tracked pharmacists that dispensed a low rate of controlled substances through its ‘Non-dispensing Pharmacist Report,’” the suit said.

“Walgreens created this metric in part because it believed pharmacists who refused to fill controlled-substance prescriptions compromised Walgreens’s customer service.”

This post appeared first on NBC NEWS

previous post
Obama wishes wife Michelle happy birthday as she stays away from key public events
next post
Tech 5: Trump to Prioritize Crypto, Biden Blocks AI Chip Exports

You may also like

Disney tops quarterly profit estimates, but starts to...

February 6, 2025

Even at $8M per Super Bowl commercial, ad...

February 8, 2025

GM to invest $625 million in joint venture...

October 17, 2024

Art created autonomously by AI can’t be copyrighted,...

March 21, 2025

Here’s what the NBA’s new media deal means...

July 26, 2024

Walmart employees are now wearing body cameras in...

December 18, 2024

Pepsi sued by federal regulators for giving Walmart...

January 18, 2025

Boeing strike ends after machinists approve new labor...

November 6, 2024

Meta announces 5% cuts in preparation for ‘intense...

January 16, 2025

Capital One acknowledges ‘outage’ as users report issues...

January 17, 2025

Recent Posts

  • Inside Epstein’s infamous ‘birthday book’: Clinton’s note, poolside candids and bizarre animal pics
  • Whole milk makes a comeback in new MAHA children’s health strategy
  • Hawley pushes legal action against Meta after whistleblowers detail child abuse in VR
  • As Trump’s bawdy birthday message to Jeffrey Epstein appears, he still insists he never sent it
  • Elon Musk agrees with JD Vance on the ‘big lie the Democrats told about violent crime’

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (913)
    • Investing (2,932)
    • Politics (3,601)
    • Stock (4)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 Sightful Invest. All Rights Reserved.